Overview

Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: Assess the safety and long-term efficacy of monoclonal factor IX concentrate in patients with factor IX deficiency.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborator:
University of North Carolina